What are Halozyme Therapeutics's profit margins?

Halozyme Therapeutics (HALO) runs a 82.8% gross margin and a 59.3% operating margin, with a 47.9% net margin.

Where do Halozyme Therapeutics's ratios come from?

Every ratio is computed from Halozyme Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Halozyme Therapeutics HALO Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	82.8%-0.8pp	83.6%-0.9pp	84.5%+0.3pp	84.2%+0.8pp	83.4%-0.9pp
Free cash flow margin	44.3%-1.9pp	46.2%-2.3pp	48.5%+2.6pp	45.9%+0.2pp	45.7%-0.4pp
Efficiency
Asset turnover	0.6×0.0×	0.6×0.0×	0.6×0.0×	0.6×0.0×	0.5×0.0×
Inventory turnover	10.8×+4.7×	6×—	——	——	——
Liquidity
Current ratio	2.8×-1.9×	4.7×+3.1×	1.6×-6.8×	8.4×0.0×	8.4×+0.6×
Quick ratio	2.7×-1.8×	4.5×+3.0×	1.6×-6.6×	8.1×0.0×	8.2×+0.8×
Cash ratio	0.9×+0.1×	0.8×+0.3×	0.5×0.0×	0.5×-0.7×	1.2×+0.3×
Leverage
Debt-to-equity	9.9×-34.7×	44.6×+41.5×	3.1×-1.6×	4.6×+1.4×	3.2×-1.0×
Debt-to-assets	0.8×0.0×	0.9×+0.2×	0.7×-0.1×	0.7×0.0×	0.7×0.0×
Per Share
Book value per share	$1.79+354%	$0.39-90.4%	$4.12+53.7%	$2.68-29.6%	$3.81+35.5%
Valuation
Market capitalization	$7.66B-3.3%	$7.91B-7.7%	$8.58B+29.2%	$6.64B-15.7%	$7.88B+29.6%
Enterprise value	$9.52B-4.3%	$9.96B+2.7%	$9.7B+19.5%	$8.12B-12.2%	$9.24B+23.2%
Price / sales	5.1×-0.6×	5.7×-1.2×	6.9×+1.3×	5.6×-1.6×	7.3×+1.3×
Price / book	34.9×-127×	162.1×+145×	17×-2.9×	20×+3.6×	16.3×-0.4×
EV / sales	6.3×-0.8×	7.1×-0.7×	7.8×+0.9×	6.9×-1.6×	8.5×+1.1×
Free cash flow yield	8.7%+0.6pp	8.1%+1.1pp	7%-1.1pp	8.1%+1.9pp	6.3%-1.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Halozyme Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Halozyme Therapeutics's profit margins?: Halozyme Therapeutics (HALO) runs a 82.8% gross margin and a 59.3% operating margin, with a 47.9% net margin.
Where do Halozyme Therapeutics's ratios come from?: Every ratio is computed from Halozyme Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.